Anti-PD-L1 Armored Anti-CD22 CAR-T/CAR-TILs Targeting Patients With Solid Tumors

计划入组 30 人 · 首次发布于 2020 年 9 月 21 日

IL13Rα2 CAR-T Cells Secreting Anti-PD-L1 Antibody for Recurrent Malignant Glioma

计划入组 24 人 · 首次发布于 2026 年 3 月 19 日

Umbilical CB-NK Expressing sIL-15 & PD-L1 +/- Atezolizumab in NSCLC Pts Refractory to PD-1/PD-L1

计划入组 9 人 · 首次发布于 2025 年 7 月 8 日

anti-PD-L1 CAR NK-cell therapy

PD-L1 CAR K-NK cells(Sanofi)

Anti-CAR-NK Cells

PD-RX Pharmaceuticals, Inc.

United States

Mister Car Wash

United States

Novel Anti-Infective Technologies, LLC

India's Technology Development Board Funds Indigenous CAR-NK Cell Therapy Platform for Cancer and Leishmaniasis Treatment

CStone Strikes Oceania Deal with Arrotex for Anti-PD-L1 Antibody Sugemalimab

ASC22 and Chidamide Combination Shows Promise in Reducing HIV Reservoir Size